| Radiation oncology in the era of precision medicine M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ... Nature Reviews Cancer 16 (4), 234-249, 2016 | 832 | 2016 |
| Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer D Zips, K Zöphel, N Abolmaali, R Perrin, A Abramyuk, R Haase, S Appold, ... Radiotherapy and Oncology 105 (1), 21-28, 2012 | 394* | 2012 |
| Glycolytic metabolism and tumour response to fractionated irradiation UGA Sattler, SS Meyer, V Quennet, C Hoerner, H Knoerzer, C Fabian, ... Radiotherapy and oncology 94 (1), 102-109, 2010 | 253 | 2010 |
| CD 8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre … P Balermpas, F Rödel, C Rödel, M Krause, A Linge, F Lohaus, ... International journal of cancer 138 (1), 171-181, 2016 | 231 | 2016 |
| Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice V Quennet, A Yaromina, D Zips, A Rosner, S Walenta, M Baumann, ... Radiotherapy and Oncology 81 (2), 130-135, 2006 | 231 | 2006 |
| A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling S Leger, A Zwanenburg, K Pilz, F Lohaus, A Linge, K Zöphel, J Kotzerke, ... Scientific reports 7 (1), 13206, 2017 | 226 | 2017 |
| Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation A Yaromina, M Krause, H Thames, A Rosner, M Krause, F Hessel, ... Radiotherapy and oncology 83 (3), 304-310, 2007 | 175 | 2007 |
| New anticancer agents: in vitro and in vivo evaluation D Zips, HD Thames, M Baumann in vivo 19 (1), 1-7, 2005 | 172 | 2005 |
| Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell … M Baumann, T Herrmann, R Koch, W Matthiessen, S Appold, B Wahlers, ... Radiotherapy and Oncology 100 (1), 76-85, 2011 | 166 | 2011 |
| HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a … F Lohaus, A Linge, I Tinhofer, V Budach, E Gkika, M Stuschke, ... Radiotherapy and oncology 113 (3), 317-323, 2014 | 163 | 2014 |
| Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ... The Lancet Oncology 21 (4), 581-592, 2020 | 155 | 2020 |
| HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary … A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ... Radiotherapy and Oncology 121 (3), 364-373, 2016 | 153 | 2016 |
| Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging S Löck, R Perrin, A Seidlitz, A Bandurska-Luque, S Zschaeck, K Zöphel, ... Radiotherapy and Oncology 124 (3), 533-540, 2017 | 148 | 2017 |
| Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG A Linge, S Löck, V Gudziol, A Nowak, F Lohaus, C von Neubeck, M Jütz, ... Clinical cancer research 22 (11), 2639-2649, 2016 | 133 | 2016 |
| Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial S Welz, D Mönnich, C Pfannenberg, K Nikolaou, M Reimold, ... Radiotherapy and Oncology 124 (3), 526-532, 2017 | 127 | 2017 |
| Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets T Skripcak, C Belka, W Bosch, C Brink, T Brunner, V Budach, D Büttner, ... Radiotherapy and Oncology 113 (3), 303-309, 2014 | 126 | 2014 |
| Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlateswith reoxygenation C Petersen, D Zips, M Krause, K Schöne, W Eicheler, C Hoinkis, ... International Journal of Radiation Oncology* Biology* Physics 51 (2), 483-493, 2001 | 125 | 2001 |
| Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in … A Yaromina, D Zips, HD Thames, W Eicheler, M Krause, A Rosner, ... Radiotherapy and oncology 81 (2), 122-129, 2006 | 124 | 2006 |
| Cancer stem cells and radiotherapy M Baumann, M Krause, H Thames, K Trott, D Zips International journal of radiation biology 85 (5), 391-402, 2009 | 119 | 2009 |
| Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis A Jakobi, A Bandurska-Luque, K Stützer, R Haase, S Löck, LJ Wack, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 1165-1174, 2015 | 117 | 2015 |
